[1] Tomasoni D, Adamo M, Lombardi CM, et al. Highlights in heart failure. ESC Heart Fail 2019; 6: 1105−1127. doi: 10.1002/ehf2.12555 [2] Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163−2196. doi: 10.1016/S0140-6736(12)61729-2 [3] Wang H, Chai K, Du M, et al. Prevalence and incidence of heart failure among urban patients in China: a national population-based analysis. Circ Heart Fail 2021; 14: e008406. doi: 10.1161/CIRCHEARTFAILURE.121.008406 [4] Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007; 93: 1137−1146. doi: 10.1136/hrt.2003.025270 [5]

Gu DF, Huang GY, He J, et al. [Investigation of prevalence and distributing feature of chronic heart failure in Chinease adult population]. Zhonghua Xin Xue Guan Bing Za Zhi 2003; 31: 3−6. [In Chinese].

[6] Hao G, Wang X, Chen Z, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015. Eur J Heart Fail 2019; 21: 1329−1337. doi: 10.1002/ejhf.1629 [7] Deng H, Guo P, Zheng M, et al. Epidemiological characteristics of atrial fibrillation in southern China: results from the Guangzhou Heart Study. Sci Rep 2018; 8: 17829. doi: 10.1038/s41598-018-35928-w [8] Fu L, Deng H, Lin WD, et al. Association between elevated blood glucose level and non-valvular atrial fibrillation: a report from the Guangzhou Heart Study. BMC Cardiovasc Disord 2019; 19: 270. doi: 10.1186/s12872-019-1253-6 [9] Lin WD, Deng H, Guo P, et al. High prevalence of hyperuricaemia and its impact on non-valvular atrial fibrillation: the cross-sectional Guangzhou (China) Heart Study. BMJ Open 2019; 9: e028007. doi: 10.1136/bmjopen-2018-028007 [10] Redfield MM, Jacobsen SJ, Burnett JC Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194−202. doi: 10.1001/jama.289.2.194 [11] Triposkiadis F, Xanthopoulos A, Butler J. Cardiovascular aging and heart failure: JACC review topic of the week. J Am Coll Cardiol 2019; 74: 804−813. doi: 10.1016/j.jacc.2019.06.053 [12] Truby LK, Rogers JG. Advanced heart failure: epidemiology, diagnosis, and therapeutic approaches. JACC Heart Fail 2020; 8: 523−536. doi: 10.1016/j.jchf.2020.01.014 [13] Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J 1994; 72: S3−S9. doi: 10.1136/hrt.72.2_suppl.s3 [14] Webb CL, Jenkins KJ, Karpawich PP, et al. Collaborative care for adults with congenital heart disease. Circulation 2002; 105: 2318−2323. doi: 10.1161/01.CIR.0000017557.24261.A7 [15] Goldberg RJ, Spencer FA, Farmer C, et al. Incidence and hospital death rates associated with heart failure: a community-wide perspective. Am J Med 2005; 118: 728−734. doi: 10.1016/j.amjmed.2005.04.013 [16] Crespo-Leiro MG, Barge-Caballero E. Advanced heart failure: definition, epidemiology, and clinical course. Heart Fail Clin 2021; 17: 533−545. doi: 10.1016/j.hfc.2021.06.002 [17] Yang Y, Wang Z, Chen Z, et al. Current status and etiology of valvular heart disease in China: a population-based survey. BMC Cardiovasc Disord 2021; 21: 339. doi: 10.1186/s12872-021-02154-8 [18] Liu FZ, Xue YM, Liao HT, et al. Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of southern China. J Thorac Dis 2014; 6: 1724−1730. doi: 10.3978/j.issn.2072-1439.2014.11.21 [19] Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 62: e147−e239. doi: 10.1016/j.jacc.2013.05.019 [20] Senni M, Iorio A, Seferović P. Heart failure with preserved ejection fraction in Asia: the far side of the moon? Eur J Heart Fail 2019; 21: 37−39. doi: 10.1002/ejhf.1335 [21] Tromp J, Teng TH, Tay WT, et al. Heart failure with preserved ejection fraction in Asia. Eur J Heart Fail 2019; 21: 23−36. doi: 10.1002/ejhf.1227 [22] Zhang Y, Zhang J, Butler J, et al. Contemporary epidemiology, management, and outcomes of patients hospitalized for heart failure in China: results from the China Heart Failure (China-HF) Registry. J Card Fail 2017; 23: 868−875. doi: 10.1016/j.cardfail.2017.09.014 [23] Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol 2011; 8: 30−41. doi: 10.1038/nrcardio.2010.165 [24] Conrad N, Judge A, Tran J, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet 2018; 391: 572−580. doi: 10.1016/S0140-6736(17)32520-5 [25] Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347: 1397−1402. doi: 10.1056/NEJMoa020265 [26] Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004; 292: 344−350. doi: 10.1001/jama.292.3.344 [27] Tseng CH. The age- and sex-specific incidence and medical expenses of heart failure hospitalization in 2005 in Taiwan: a study using data from the National Health Insurance. J Am Geriatr Soc 2010; 58: 611−613. doi: 10.1111/j.1532-5415.2010.02755.x [28]

Hung YT, Cheung NT, Ip S, et al. Epidemiology of heart failure in Hong Kong, 1997. Hong Kong Med J 2000; 6: 159−162.

[29] Du X, Patel A, Anderson CS, et al. Epidemiology of cardiovascular disease in China and opportunities for improvement: JACC international. J Am Coll Cardiol 2019; 73: 3135−3147. doi: 10.1016/j.jacc.2019.04.036 [30] Zhao D, Liu J, Wang M, et al. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol 2019; 16: 203−212. doi: 10.1038/s41569-018-0119-4